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Approximately 22,000 U.S. women are newly diagnosed each year with epithelial 
ovarian cancer (EOC), 75% of whom present with existing metastases and peritoneal 
ascites. A key event in EOC metastasis is disruption of cell-cell contacts via 
modulation of intercellular junctional components such as cadherins.  In contrast to 
most carcinomas, EOC actually gain expression of the cell-cell adhesion molecule E-
cadherin.  Ovarian cancer metastasizes via exfoliation of cells from the primary tumor 
to the peritoneal cavity, wherein free-floating cells and multi-cellular aggregates 
attach and invade to anchor growth of secondary lesions.  Ascites is also rich in 
lysophosphatidic acid (LPA), a bioactive lipid that is a sensitive biomarker for 
ovarian cancer and may promote early events in ovarian cancer dissemination.  The 
objective of this study was to determine whether LPA modulates E-cadherin 
junctional integrity.  Immunofluorescence analyses were used to demonstrate a loss of 
junctional E-cadherin in OvCar3, OvCa429 and OvCa433cells exposed to LPA.  
LPA-induced loss of E-cadherin was concentration-and time-dependent.  Surface 
labeling and western blotting showed that LPA promoted E-cadherin ectodomain 
shedding. Matrix metalloproteinase-9 (MMP9) expression was also induced by LPA 
treatment and inhibition of MMP9 activity blocked E-cadherin ectodomain shedding.   
Blocking LPA receptor signaling using the compound LPAR1 inhibited MMP9 
expression and restored junctional E-cadherin staining.  These data support a model 
wherein LPA induces MMP9 expression and MMP9-catalyzed E-cadherin 
ectodomain shedding, resulting in a loss of E-cadherin junctional integrity, facilitating 
metastatic dissemination of ovarian cancer cells.  
 
